INAB

In8Bio, Inc.

• Reuters·5d ago

  IN8bio grants 11,800 inducement stock options to new hires under Nasdaq rule

• Reuters·5d ago

  IN8BIO REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

• Reuters·03/26 20:09

  IN8bio announces 2026 annual stockholders meeting; FY2025 audit fees rise to $399,889

• Reuters·03/17 14:10

  IN8BIO Inc. publishes corporate presentation on gamma-delta T cell therapies in oncology and autoimmune diseases

• Dow Jones·03/13 12:11

  IN8bio Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

• Benzinga·03/13 12:01

  HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $6 Price Target

• TipRanks·03/13 11:50

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Korro Bio (KRRO), IN8bio (INAB) and Aveanna Healthcare Holdings (AVAH)

• TipRanks·03/13 01:10

  Analysts Are Bullish on Top Healthcare Stocks: HeartBeam (BEAT), IN8bio (INAB)

• Reuters·03/12 20:45

  IN8bio Q4 net loss narrows, cash position more than doubles

• Dow Jones·03/12 20:06

  *IN8bio Sees Guidance From FDA on Potential Regulatory Pathway by 2H

• Dow Jones·03/12 20:06

  *IN8bio: Initial Preclinical Animal Data and Additional IND-enabling Data for INB-619 Expected in 2H >INAB

• Dow Jones·03/12 20:06

  *IN8bio 4Q Loss $4.9M >INAB

• Reuters·03/12 20:05

  IN8bio FY 2025 net loss narrows 36% to USD 19.4 million

• Seeking Alpha·03/12 20:05

  IN8bio GAAP EPS of -$4.44 misses by $1.22

• Reuters·03/12 20:01

  IN8BIO INC - Q4 NET LOSS $0.45 PER SHARE